首页 | 本学科首页   官方微博 | 高级检索  
     

低分子量肝素预防ERCP术后急性胰腺炎的临床研究
引用本文:胡国潢,段炼,周军,汤恢焕,吕新生. 低分子量肝素预防ERCP术后急性胰腺炎的临床研究[J]. 中国普通外科杂志, 2006, 15(10): 17-787
作者姓名:胡国潢  段炼  周军  汤恢焕  吕新生
作者单位:中南大学湘雅医院,普通外科,湖南,长沙,410008
摘    要:目的:探讨低分子量肝素(LMWH)预防ERCP术后急性胰腺炎发生的作用。方法:将60例患者随机分成ERCP组(E组)和ERCP术前LMWH预处理组(H组),每组30例。观察ERCP术后患者的腹痛程度,血清淀粉酶( AMS),内毒素(ET),一氧化氮(NO)、白细胞介素6(IL-6)等生化指标以及B超下胰腺形态学变化;观察H组术前术后的凝血功能变化。结果:E组腹痛症状加重者5例(16.7%,5/30),明显高于H组(0,0/30)(P<0.05)。两组患者术前各项生化指标水平均无显著差异(P>0.05),术后4h、24hE组血清ET和AMS水平明显高于H组(P<0.05),24h达高峰;E组血清NO水平明显低于H组(P<0.05);E组各时点IL-6水平均明显高于H组(均P<0.05)。B超下E组1例胰腺有急性炎性改变,H组无凝血功能变化。结论:LMWH能预防或减轻ERCP术后胰腺急性炎症的发生,是一种简便、经济而安全的方法。其机制可能是通过改善微循环、降低炎症介质水平来实现的。

关 键 词:急性胰腺炎/预防  经内镜逆行性胰胆管造影  低分子量肝素
文章编号:1005-6947(2006)10-0784-04
收稿时间:2006-08-11
修稿时间:2006-09-25

Clinical study on the prevention of acute pancreatitis after ERCP with low molecular weight heparin
HU Guo-huang,DUAN Lian,ZHOU Jun,TANG Hui-huan,LU Xinsheng. Clinical study on the prevention of acute pancreatitis after ERCP with low molecular weight heparin [J]. Chinese Journal of General Surgery, 2006, 15(10): 17-787
Authors:HU Guo-huang  DUAN Lian  ZHOU Jun  TANG Hui-huan  LU Xinsheng
Affiliation:Department of General Surgery, Xiang Ya Hospital, Central South University, Changsha 410008, China
Abstract:Objective To explore whether low molecular weight heparin(LMWH) could prevent acute(pancreatitis) after ERCP and its clinical significance.Methods Sixty patients were randomly divided into 2 groups(30 in each group): ERCP group (E group),LMWH prevention group(H group).Changes of(abdominal) pain,biochemical parameters of amylase(AMS),endotoxin(ET),interleukin-6(IL6),nitricogen oxide(NO) and pancreatic morphology under ultrasonography between the two groups were investigated.(Changes) of coagulation function in H group before and after ERCP were also studied.Results Abdominal pain of 5 patients in E group(16.7%) was aggravated,but none of H group.There were no significant differences in the values of biochemical parameters and pancreatic morphology between the two groups before ERCP.The values of AMS,ET in E group were significantly higher at 4h and 24h after ERCP than those of H group(P<0.05);meanwhile the values of NO in H group were significantly higher at 4h and 24h than those of E group(P<0.05).The values of IL6 in E group were significantly higher after ERCP than those of H group at all time points(P<0.05).One patient in E group had acute inflammatory change of(pancreas) under ultrasonography.No obvious change of coagulation function was observed after ERCP in H group(P>0.05).Conclusions LMWH therapy may prevent or reduce the occurrence of acute(pancreatitis) in those who undergo ERCP by improving microcirculation and reducing the release of inflammatory mediators,and is a simple,economic and safe method.
Keywords:Acute Pancreatitis/prev   ERCP   Low Molecular Weight Heparin
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号